UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Experience of anti-IL-1β and anti-IL-18 combined therapy (MAS825) in recurrent and recalcitrant macrophage activation syndrome

Rheumatology (Oxford, England), 2024-04, Vol.63 (4), p.e129-e131

2024

Volltextzugriff (PDF)

Cardiac involvement in multisystem inflammatory syndrome in children: single-centre experience

Cardiology in the young, 2023-07, Vol.33 (7), p.1117-1123

2023

Volltextzugriff (PDF)

A rare onset in tumour necrosis factor receptor-associated periodic syndrome: recurrent macrophage activation syndrome triggered by COVID-19 infection

Rheumatology (Oxford, England), 2022-11, Vol.61 (12), p.e366-e367

2022

Volltextzugriff (PDF)

Real-life data on efficacy and safety of original Adalimumab and biosimilar Adalimumab (ABP 501) in pediatric rheumatic diseases

Expert opinion on biological therapy, 2023-08, Vol.ahead-of-print (ahead-of-print), p.1-7

2023

Volltextzugriff (PDF)

The cultural differences in transition assessment: Evaluation of TRANSITION-Q and STARx scales on Turkish rheumatic patients

Archives of rheumatology, 2024-06, Vol.39 (2), p.255-264

2024

Volltextzugriff (PDF)

Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience

Pediatric rheumatology online journal, 2023-11, Vol.21 (1), p.140-140, Article 140

2023

Volltextzugriff (PDF)

Not easy-peasy to diagnose: familial Mediterranean fever unaccompanied by fever

European journal of pediatrics, 2023-09, Vol.182 (9), p.3983-3988

2023

Volltextzugriff (PDF)

Evaluation of childhood malignancies presenting with musculoskeletal manifestations from two different divisions: a multicenter study

The Turkish journal of pediatrics, 2024-01, Vol.66 (1), p.81-89

2024

Volltextzugriff (PDF)

The assessment of autoinflammatory disease classification criteria (Eurofever/PRINTO) in a real-life cohort

Clinical rheumatology, 2023-06, Vol.42 (6), p.1645-1653

2023

Volltextzugriff (PDF)

Withdrawal of biologic therapy in juvenile idiopathic arthritis due to remission: predictors of flare and outcomes

Expert opinion on biological therapy, 2023-03, Vol.23 (3), p.305-313

2023

Volltextzugriff (PDF)

How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience

Pediatric rheumatology online journal, 2023-07, Vol.21 (1), p.72-72, Article 72

2023

Volltextzugriff (PDF)

The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center

Postgraduate medicine, 2021-11, Vol.133 (8), p.994-1000

2021

Volltextzugriff (PDF)

The Multifaceted Presentation of the Multisystem Inflammatory Syndrome in Children: Data from a Cluster Analysis

Journal of clinical medicine, 2022-03, Vol.11 (6), p.1742

2022

Volltextzugriff (PDF)

Is it all about age? Clinical characteristics of Kawasaki disease in the extremely young: PeRA research group experience

Postgraduate medicine, 2022-05, Vol.134 (4), p.429-434

2022

Volltextzugriff (PDF)

Mepolizumab therapy in a pediatric patient with eosinophilic granulomatosis with polyangiitis associated with refractory myocarditis

Archives of rheumatology, 2023-06, Vol.38 (2), p.326-328

2023

Volltextzugriff (PDF)

Real-life data of etanercept efficacy and safety in juvenile idiopathic arthritis: a 24-month retrospective study at a single center

Expert opinion on biological therapy, 2024-08

2024

Volltextzugriff (PDF)

Clinical course of COVID-19 in children with rheumatic disease under biologic therapy

Clinical and experimental rheumatology, 2021-01, Vol.39 Suppl 128 (1), p.36

2021

Volltextzugriff (PDF)

61 The nailfold videocapillaroscopy in pediatric Behçet’s disease: a multi-center study

Rheumatology (Oxford, England), 2022-10, Vol.61 (Supplement_2)

2022

Volltextzugriff (PDF)

004 Systemic autoinflammatory diseases: a multicenter cohort study

Rheumatology (Oxford, England), 2022-10, Vol.61 (Supplement_2)

2022

Volltextzugriff (PDF)

Remission rates and risk factors for relapse in pediatric morphea: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG)

Clinical rheumatology, 2023-10, Vol.42 (10), p.2855-2860

2023

Volltextzugriff (PDF)

Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study

Rheumatology international, 2022-05, Vol.42 (5), p.879-889

2022

Volltextzugriff (PDF)

The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study

Expert opinion on biological therapy, 2023-12, Vol.23 (12), p.1299-1306

2023

Volltextzugriff (PDF)

PREDICT-crFMF score: A novel model for predicting colchicine resistance in children with familial Mediterranean fever

Modern rheumatology, 2023-12, Vol.34 (1), p.220-225

2023

Volltextzugriff (PDF)

Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study

Pediatric rheumatology online journal, 2024-01, Vol.22 (1), p.7-7, Article 7

2024

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(37)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Rheumatology
(19)
Humans
(15)
Pediatrics
(12)
Patients
(10)
Child
(8)
Fever
(8)
Retrospective Studies
(6)
Arthritis
(5)
Covid-19
(5)
Female
(5)
General & Internal Medicine
(5)
Male
(5)
Medical Research
(5)
Medicine, General & Internal
(5)
Multisystem Inflammatory Syndrome In Children
(5)
Remission
(5)
Disease
(4)
Familial Mediterranean Fever
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Experience of anti-IL-1β and anti-IL-18 combined therapy (MAS825) in recurrent and recalcitrant macrophage activation syndrome

Cardiac involvement in multisystem inflammatory syndrome in children: single-centre experience

A rare onset in tumour necrosis factor receptor-associated periodic syndrome: recurrent macrophage activation syndrome triggered by COVID-19 infection

Real-life data on efficacy and safety of original Adalimumab and biosimilar Adalimumab (ABP 501) in pediatric rheumatic diseases

The cultural differences in transition assessment: Evaluation of TRANSITION-Q and STARx scales on Turkish rheumatic patients

Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience

Not easy-peasy to diagnose: familial Mediterranean fever unaccompanied by fever

Evaluation of childhood malignancies presenting with musculoskeletal manifestations from two different divisions: a multicenter study

The assessment of autoinflammatory disease classification criteria (Eurofever/PRINTO) in a real-life cohort

Withdrawal of biologic therapy in juvenile idiopathic arthritis due to remission: predictors of flare and outcomes

How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience

The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center

The Multifaceted Presentation of the Multisystem Inflammatory Syndrome in Children: Data from a Cluster Analysis

Is it all about age? Clinical characteristics of Kawasaki disease in the extremely young: PeRA research group experience

Mepolizumab therapy in a pediatric patient with eosinophilic granulomatosis with polyangiitis associated with refractory myocarditis

Real-life data of etanercept efficacy and safety in juvenile idiopathic arthritis: a 24-month retrospective study at a single center

Clinical course of COVID-19 in children with rheumatic disease under biologic therapy

61 The nailfold videocapillaroscopy in pediatric Behçet’s disease: a multi-center study

004 Systemic autoinflammatory diseases: a multicenter cohort study

Remission rates and risk factors for relapse in pediatric morphea: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG)

Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or -6 therapy

Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study

The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study

PREDICT-crFMF score: A novel model for predicting colchicine resistance in children with familial Mediterranean fever

Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study

Suchergebnisse filtern